Quick Answer
Hepion Pharmaceuticals, Inc. reported Total Assets of $3.07 million for fiscal year 2025.
Hepion Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $3.07M | +90.2% |
| 2024 | $1.61M | -91.1% |
| 2023 | $18.09M | -70.0% |
| 2022 | $60.24M | -41.8% |
| 2021 | $103.55M | +112.9% |
| 2020 | $48.65M | +136.0% |
| 2019 | $20.61M | +151.7% |
| 2018 | $8.19M | -27.2% |
| 2017 | $11.25M | -38.8% |
| 2017 | $18.38M | +40.3% |
| 2016 | $13.11M | +143.7% |
| 2015 | $5.38M | +168.7% |
| 2014 | $2.00M | +2207.4% |
| 2013 | $86.7K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.74M | +0.7% | -17.0% |
| June 30, 2025 | $4.51M | -25.0% | -28.7% |
| March 31, 2025 | $6.32M | -60.5% | +291.5% |
| December 31, 2024 | $1.61M | -91.1% | -56.6% |
| September 30, 2024 | $3.72M | -85.1% | -38.2% |
| June 30, 2024 | $6.01M | -83.5% | -62.4% |
| March 31, 2024 | $15.99M | -67.7% | -11.6% |
| December 31, 2023 | $18.09M | -70.0% | -27.6% |
- Hepion Pharmaceuticals, Inc. showed an increase of +90.2% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Hepion Pharmaceuticals, Inc.’s total assets has grown by 3440.2% (from $86.7 thousand to $3.07 million).
- The most recent figure is from Hepion Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: